Javier E Villanueva-Meyer
Overview
Explore the profile of Javier E Villanueva-Meyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
1996
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ellingson B, Sanvito F, Pope W, Cloughesy T, Huang R, Villanueva-Meyer J, et al.
AJNR Am J Neuroradiol
. 2024 Dec;
46(1):221-222.
PMID: 39730160
No abstract available.
2.
Lucas C, Al-Adli N, Young J, Gupta R, Morshed R, Wu J, et al.
Neuro Oncol
. 2024 Nov;
27(1):89-105.
PMID: 39560080
Background: Despite recent advances in the biology of IDH-wildtype glioblastoma, it remains a devastating disease with median survival of less than 2 years. However, the molecular underpinnings of the heterogeneous...
3.
Bakas S, Vollmuth P, Galldiks N, Booth T, Aerts H, Bi W, et al.
Lancet Oncol
. 2024 Oct;
25(11):e589-e601.
PMID: 39481415
Technological advancements have enabled the extended investigation, development, and application of computational approaches in various domains, including health care. A burgeoning number of diagnostic, predictive, prognostic, and monitoring biomarkers are...
4.
Villanueva-Meyer J, Bakas S, Tiwari P, Lupo J, Calabrese E, Davatzikos C, et al.
Lancet Oncol
. 2024 Oct;
25(11):e581-e588.
PMID: 39481414
The development, application, and benchmarking of artificial intelligence (AI) tools to improve diagnosis, prognostication, and therapy in neuro-oncology are increasing at a rapid pace. This Policy Review provides an overview...
5.
Eaton C, Avalos L, Liu S, Chen Z, Zakimi N, Casey-Clyde T, et al.
Nat Commun
. 2024 Sep;
15(1):7873.
PMID: 39251601
Meningiomas are associated with inactivation of NF2/Merlin, but approximately one-third of meningiomas with favorable clinical outcomes retain Merlin expression. Biochemical mechanisms underlying Merlin-intact meningioma growth are incompletely understood, and non-invasive...
6.
Ellingson B, Sanvito F, Cloughesy T, Huang R, Villanueva-Meyer J, Pope W, et al.
AJNR Am J Neuroradiol
. 2024 Jun;
45(12):1846-1856.
PMID: 38926092
Radiographic assessment plays a crucial role in the management of patients with central nervous system (CNS) tumors, aiding in treatment planning and evaluation of therapeutic efficacy by quantifying response. Recently,...
7.
Fields B, Calabrese E, Mongan J, Cha S, Hess C, Sugrue L, et al.
Radiol Artif Intell
. 2024 Jun;
6(4):e230182.
PMID: 38864741
8.
Ellison J, Caliva F, Damasceno P, Luks T, Lafontaine M, Cluceru J, et al.
Bioengineering (Basel)
. 2024 May;
11(5).
PMID: 38790363
Although fully automated volumetric approaches for monitoring brain tumor response have many advantages, most available deep learning models are optimized for highly curated, multi-contrast MRI from newly diagnosed gliomas, which...
9.
Liu J, Jakary A, Villanueva-Meyer J, Butowski N, Saloner D, Clarke J, et al.
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672606
This study aimed to develop a rapid, 1 mm isotropic resolution, whole-brain MRI technique for automatic lesion segmentation and multi-parametric mapping without using contrast by continuously applying balanced steady-state free...
10.
Narsinh K, Perez E, Haddad A, Young J, Savastano L, Villanueva-Meyer J, et al.
Curr Neurol Neurosci Rep
. 2024 Apr;
24(5):123-139.
PMID: 38578405
Purpose Of Review: Glioblastoma remains resistant to most conventional treatments. Despite scientific advances in the past three decades, there has been a dearth of effective new treatments. New approaches to...